Cell-free placental DNA: What do we really know?

Area of Science:

• Reproductive Biology
• Genetics
• Molecular Diagnostics

Background:

• Cell-free placental DNA (cfpDNA) circulates in maternal blood during pregnancy.
• It enables non-invasive investigation of the placental epigenome, bypassing the need for invasive procedures.
• Clinical use is established in non-invasive prenatal testing (NIPT), but fundamental biology is unclear.

Purpose of the Study:

• To review current knowledge on the origins and molecular characteristics of cfpDNA.
• To identify knowledge gaps in cfpDNA biology.
• To propose future research directions for cfpDNA.

Main Methods:

• Literature review of existing studies on cfpDNA.
• Analysis of current understanding of cfpDNA origins.
• Examination of cfpDNA molecular properties.

Main Results:

• cfpDNA originates from the placenta and is detectable in maternal circulation.
• Its molecular characteristics, such as size and epigenetic modifications, are under investigation.
• Significant gaps exist in understanding its release, clearance, and precise biological roles.

Conclusions:

• Further research into cfpDNA biology is essential to maximize its potential in research and clinical applications.
• Understanding cfpDNA will enhance its utility beyond current NIPT applications.
• Addressing knowledge gaps will facilitate novel diagnostic and therapeutic strategies.